Sarepta Therapeutics Inc (SRPT) — Cash Flow-to-Debt Ratio
Sarepta Therapeutics Inc (SRPT) has a Cash Flow-to-Debt Ratio of -0.12x as of March 2026, meaning its operating cash flow of $-202.68 Million could theoretically repay 0% of its total liabilities ($1.67 Billion) in one year. Explore Sarepta Therapeutics Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sarepta Therapeutics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Sarepta Therapeutics Inc across 31 annual periods. Also explore total assets of Sarepta Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sarepta Therapeutics Inc (1995–2025)
Year-by-year debt coverage analysis for Sarepta Therapeutics Inc. For market capitalisation and broader financial context, see market cap of Sarepta Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | $-205.48 Million | $2.21 Billion | ▼ -10.1% |
| 2024 | -0.08x | $-205.79 Million | $2.44 Billion | ▲ +59.4% |
| 2023 | -0.21x | $-500.99 Million | $2.41 Billion | ▼ -75.6% |
| 2022 | -0.12x | $-325.35 Million | $2.74 Billion | ▲ +40.6% |
| 2021 | -0.20x | $-443.17 Million | $2.22 Billion | ▼ -512.9% |
| 2020 | 0.05x | $107.47 Million | $2.22 Billion | ▲ +110.6% |
| 2019 | -0.45x | $-456.46 Million | $1.00 Billion | ▲ +28.7% |
| 2018 | -0.64x | $-388.66 Million | $609.80 Million | ▼ -42.5% |
| 2017 | -0.45x | $-232.00 Million | $518.75 Million | ▲ +84.1% |
| 2016 | -2.81x | $-245.82 Million | $87.41 Million | ▼ -57.0% |
| 2015 | -1.79x | $-149.47 Million | $83.44 Million | ▲ +34.0% |
| 2014 | -2.71x | $-128.54 Million | $47.38 Million | ▼ -86.1% |
| 2013 | -1.46x | $-64.69 Million | $44.38 Million | ▼ -299.2% |
| 2012 | -0.37x | $-29.69 Million | $81.31 Million | ▲ +64.0% |
| 2011 | -1.01x | $-23.68 Million | $23.35 Million | ▼ -225.3% |
| 2010 | -0.31x | $-15.21 Million | $48.79 Million | ▼ -28.9% |
| 2009 | -0.24x | $-8.80 Million | $36.40 Million | ▲ +80.8% |
| 2008 | -1.26x | $-12.34 Million | $9.80 Million | ▲ +37.5% |
| 2007 | -2.01x | $-24.68 Million | $12.26 Million | ▲ +69.2% |
| 2006 | -6.54x | $-20.61 Million | $3.15 Million | ▼ -22.6% |
| 2005 | -5.34x | $-14.67 Million | $2.75 Million | ▲ +49.5% |
| 2004 | -10.57x | $-23.78 Million | $2.25 Million | ▼ -126.8% |
| 2003 | -4.66x | $-17.48 Million | $3.75 Million | ▼ -17.8% |
| 2002 | -3.96x | $-20.26 Million | $5.12 Million | ▼ -1.2% |
| 2001 | -3.91x | $-12.82 Million | $3.28 Million | ▲ +26.2% |
| 2000 | -5.30x | $-9.13 Million | $1.72 Million | ▲ +30.3% |
| 1999 | -7.60x | $-7.60 Million | $1.00 Million | ▼ -36.1% |
| 1998 | -5.58x | $-6.70 Million | $1.20 Million | ▲ +6.9% |
| 1997 | -6.00x | $-3.00 Million | $500.00K | ▼ -1175.0% |
| 1996 | -0.47x | $-1.60 Million | $3.40 Million | ▲ +92.1% |
| 1995 | -5.93x | $-1.78 Million | $300.00K | — |